Advanced search
Publication Cover
Lung Cancer Management Volume 12, 2023 - Issue 4
Submit an article Journal homepage
327
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

A Retrospective Study of Ensartinib-Treated ALK-Positive Locally Advanced or Metastatic NSCLC Patients in China

Xiaobin Yuan1 Betta Pharmaceuticals Co., Ltd, Hangzhou, Zhejiang, 311100, ChinaView further author information
,
Yang Wang1 Betta Pharmaceuticals Co., Ltd, Hangzhou, Zhejiang, 311100, ChinaView further author information
,
Min Yang1 Betta Pharmaceuticals Co., Ltd, Hangzhou, Zhejiang, 311100, ChinaView further author information
,
Pengxiang Wu1 Betta Pharmaceuticals Co., Ltd, Hangzhou, Zhejiang, 311100, ChinaView further author information
,
Hui Chen1 Betta Pharmaceuticals Co., Ltd, Hangzhou, Zhejiang, 311100, ChinaView further author information
,
Yu Yun1 Betta Pharmaceuticals Co., Ltd, Hangzhou, Zhejiang, 311100, ChinaView further author information
,
Zhilin Shen1 Betta Pharmaceuticals Co., Ltd, Hangzhou, Zhejiang, 311100, ChinaView further author information
,
Dong Ji1 Betta Pharmaceuticals Co., Ltd, Hangzhou, Zhejiang, 311100, ChinaView further author information
,
Yongbin Ma1 Betta Pharmaceuticals Co., Ltd, Hangzhou, Zhejiang, 311100, ChinaCorrespondence[email protected]
View further author information
&
Lieming Ding1 Betta Pharmaceuticals Co., Ltd, Hangzhou, Zhejiang, 311100, ChinaCorrespondence[email protected]
View further author information
 show all
Article: LMT61 | Received 30 May 2023, Accepted 27 Sep 2023, Published online: 07 Nov 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.